1.
Reina-Llompart N, Serrano-López S, Torres-Iglesias G, Álvarez-Troncoso J. Tofacitinib improves motor symptoms in parkinsonism associated with a heterozygous NGLY1 variant and autoimmune disease. EJCRIM [Internet]. 2025 Oct. 27 [cited 2026 Nov. 18];12(11). Available from: https://ojs.wedare.app/ejcrim/article/view/5886